Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R G. Crystal

Showing results (411-420 of 431) with videos related to

Pageof 44
Sort By:
Gene Therapy|April 16, 1998
The effect of mucolytic agents on gene transfer across a CF sputum barrier in vitroM Stern, N J Caplen, J E Browning, et al.
Nature Genetics|September 1, 1994
Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosisR G Crystal, N G McElvaney, M A Rosenfeld, et al.
The Journal of Experimental Medicine|May 9, 2001
Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cellsK Hattori, S Dias, B Heissig, et al.
The Journal of Biological Chemistry|October 25, 1996
Superoxide-mediated actin response in post-hypoxic endothelial cellsL E Crawford, E E Milliken, K Irani, et al.
American Journal of Respiratory and Critical Care Medicine|March 11, 2000
Feasibility of a clinical trial of augmentation therapy for alpha(1)-antitrypsin deficiency. The Alpha 1-Antitrypsin Deficiency Registry Study GroupM D Schluchter, J K Stoller, A F Barker, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 2, 1997
Tumor necrosis factor alpha plays a central role in immune-mediated clearance of adenoviral vectorsK B Elkon, C C Liu, J G Gall, et al.
American Journal of Respiratory Cell and Molecular Biology|February 25, 1999
Modification of the genetic program of human alveolar macrophages by adenovirus vectors in vitro is feasible but inefficient, limited in part by the low level of expression of the coxsackie/adenovirus receptorR J Kaner, S Worgall, P L Leopold, et al.
AJNR. American Journal of Neuroradiology|August 19, 2007
Assessing disease severity in late infantile neuronal ceroid lipofuscinosis using quantitative MR diffusion-weighted imagingJ P Dyke, H U Voss, D Sondhi, et al.
AJNR. American Journal of Neuroradiology|January 30, 2016
Brain Region-Specific Degeneration with Disease Progression in Late Infantile Neuronal Ceroid Lipofuscinosis (CLN2 Disease)J P Dyke, D Sondhi, H U Voss, et al.
Neurology|August 8, 2007
Neurological deterioration in late infantile neuronal ceroid lipofuscinosisS Worgall, M V Kekatpure, L Heier, et al.
Pageof 44

Showing results (411-420 of 431) with videos related to

Sort By:
Pageof 44
Gene Therapy|April 16, 1998
The effect of mucolytic agents on gene transfer across a CF sputum barrier in vitroM Stern, N J Caplen, J E Browning, et al.
Nature Genetics|September 1, 1994
Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosisR G Crystal, N G McElvaney, M A Rosenfeld, et al.
The Journal of Experimental Medicine|May 9, 2001
Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cellsK Hattori, S Dias, B Heissig, et al.
The Journal of Biological Chemistry|October 25, 1996
Superoxide-mediated actin response in post-hypoxic endothelial cellsL E Crawford, E E Milliken, K Irani, et al.
American Journal of Respiratory and Critical Care Medicine|March 11, 2000
Feasibility of a clinical trial of augmentation therapy for alpha(1)-antitrypsin deficiency. The Alpha 1-Antitrypsin Deficiency Registry Study GroupM D Schluchter, J K Stoller, A F Barker, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 2, 1997
Tumor necrosis factor alpha plays a central role in immune-mediated clearance of adenoviral vectorsK B Elkon, C C Liu, J G Gall, et al.
American Journal of Respiratory Cell and Molecular Biology|February 25, 1999
Modification of the genetic program of human alveolar macrophages by adenovirus vectors in vitro is feasible but inefficient, limited in part by the low level of expression of the coxsackie/adenovirus receptorR J Kaner, S Worgall, P L Leopold, et al.
AJNR. American Journal of Neuroradiology|August 19, 2007
Assessing disease severity in late infantile neuronal ceroid lipofuscinosis using quantitative MR diffusion-weighted imagingJ P Dyke, H U Voss, D Sondhi, et al.
AJNR. American Journal of Neuroradiology|January 30, 2016
Brain Region-Specific Degeneration with Disease Progression in Late Infantile Neuronal Ceroid Lipofuscinosis (CLN2 Disease)J P Dyke, D Sondhi, H U Voss, et al.
Neurology|August 8, 2007
Neurological deterioration in late infantile neuronal ceroid lipofuscinosisS Worgall, M V Kekatpure, L Heier, et al.
Pageof 44